New Genital Herpes Vaccine Candidate Provides Powerful Protection in Preclinical Tests - Penn Medicine
Herpes Advocate on Twitter: "We've reached 5,000 members on our #HerpesCureResearch group on @reddit. Meaning, if everyone kicks in $10 we'd easily reach our goal of 50K for Dr Harvey Friedman's HSV
Now proven against coronavirus, mRNA can do so much more
Herpes vaccine is a winner in animals. Next up: Testing on humans.
mRNA: Technology used to make Pfizer, Moderna COVID vaccines tested to treat HIV, cancer, more - 6abc Philadelphia
Shingles Vaccine and IBD Research at Penn - Penn Medicine
Extremely promising new herpes vaccine moves closer to human trials
Penn Medicine on Twitter: "Congrats to #LaskerAward winners Drew Weissman & Katalin Kariko, @PennMedicine mRNA vaccine pioneers! Their revolutionary work not only set the stage for development of the COVID vaccines, but
New HSV-2 Vaccine Uses mRNA to Treat Herpes in Mice | Penn Medicine
Older Pennsylvanians Urged to Get Flu and COVID-19 Vaccines - MyChesCo
mRNA Vaccines for Infectious Diseases Beyond COVID-19 | Penn Medicine
Vaccine prevents genital herpes in animal tests - Futurity
Cureus | Reactivation of Herpes Zoster Virus After COVID-19 Vaccination: Is There Any Association? | Article
Penn's genital herpes vaccine is a winner in animals. Next up: testing on humans | Pittsburgh Post-Gazette
Penn Medicine - Home | Facebook
Penn State Health to require COVID vaxx for employees | Centre Daily Times
Cureus | Hypertrophic Perianal Herpes Mimicking Squamous Cell Cancer: A Case Report and a Review of the Literature | Article
Critical Vaccination & Transplantation Update for Community Partners - YouTube
A new herpes vaccine leaves no trace of infection or disease | Penn Today
Moderna is developing a herpes vaccine
/cloudfront-us-east-2.images.arcpublishing.com/reuters/XA3ISOF3EROIZE3YJWGU3K4IF4.jpg "BioNTech doses first patient in herpes vaccine candidate clinical trial | Reuters")
BioNTech doses first patient in herpes vaccine candidate clinical trial | Reuters
Laying the Groundwork for COVID-19 Vaccines: Dr. Drew Weissman and mRNA Technology at Penn Medicine - YouTube
BioNTech starts Phase 1 trial for herpes virus vaccine
Dr. Drew Weissman on the exciting future of mRNA | Christie's
From foundational discoveries to profound impact | Penn Today
U Penn's Herpes Vaccine Looks Great in Animals. Will it Hold Up in Humans? | American Council on Science and Health
New vaccine prevents genital herpes in mice and guinea pigs
Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes | Science Immunology
